当前位置:首页 - 行情中心 - 伟思医疗(688580) - 财务分析 - 现金流量表

伟思医疗

(688580)

  

流通市值:48.81亿  总市值:48.81亿
流通股本:9577.13万   总股本:9577.13万

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金236,082,962.93107,027,073.4458,474,244.49324,763,726.15
  收到的税费返还8,203,831.733,264,164.4615,517,933.6711,009,887.93
  收到其他与经营活动有关的现金9,615,078.066,762,350.6723,570,795.2820,361,794.09
  经营活动现金流入小计253,901,872.72117,053,588.53497,562,973.44356,135,408.17
  购买商品、接受劳务支付的现金61,510,302.0330,805,575.94115,189,768.6383,999,724.37
  支付给职工以及为职工支付的现金75,991,713.2243,783,368.47151,363,091.5118,853,074.13
  支付的各项税费29,099,421.9711,602,116.8260,040,712.7546,836,664.77
  支付其他与经营活动有关的现金22,515,471.798,459,886.9452,681,77044,673,664.55
  经营活动现金流出的平衡项目000.010
  经营活动现金流出小计189,116,909.0194,650,948.17379,275,342.89294,363,127.82
  经营活动产生的现金流量净额64,784,963.7122,402,640.36118,287,630.5561,772,280.35
二、投资活动产生的现金流量:
  收回投资收到的现金1,681,000,000791,000,0002,795,000,0001,886,000,000
  取得投资收益收到的现金6,593,169.163,126,773.5111,336,994.518,238,504.93
  处置固定资产、无形资产和其他长期资产收回的现金净额44044022,53016,530
  收到的其他与投资活动有关的现金1,200,000150,000900,000500,000
  投资活动现金流入小计1,688,793,609.16794,277,213.512,807,259,524.511,894,755,034.93
  购建固定资产、无形资产和其他长期资产支付的现金54,350,575.5334,866,799.39113,075,847.2196,190,534.5
  投资支付的现金1,681,000,000791,000,0002,795,000,0002,286,000,000
  支付其他与投资活动有关的现金1,000,000---
  投资活动现金流出小计1,736,350,575.53825,866,799.392,908,075,847.212,382,190,534.5
  投资活动产生的现金流量净额-47,556,966.37-31,589,585.88-100,816,322.7-487,435,499.57
三、筹资活动产生的现金流量:
  吸收投资收到的现金---10,913,711.2
  收到其他与筹资活动有关的现金--13,321,999.6990,150
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--13,321,999.611,903,861.2
  分配股利、利润或偿付利息支付的现金77,237,024.02-102,196,467.99102,191,193.85
  支付其他与筹资活动有关的现金146,162.66-15,194,315.8412,790,064.48
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计77,383,186.68-117,390,783.83114,981,258.33
  筹资活动产生的现金流量净额平衡项目0-00
  筹资活动产生的现金流量净额-77,383,186.68--104,068,784.23-103,077,397.13
四、汇率变动对现金及现金等价物的影响4,022.12-575.693,281.4-
五、现金及现金等价物净增加额-60,151,167.22-9,187,521.21-86,594,194.98-528,740,616.35
  加:期初现金及现金等价物余额1,067,206,832.731,067,206,832.731,153,801,027.711,153,801,027.71
  期末现金及现金等价物余额1,007,055,665.511,058,019,311.521,067,206,832.73625,060,411.36
补充资料:
  净利润69,324,242.51-101,969,230.54-
  资产减值准备--29,234.54-
  固定资产和投资性房地产折旧6,657,647.73-12,005,868.19-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧6,657,647.73-12,005,868.19-
  无形资产摊销7,894,032.23-8,714,699.4-
  长期待摊费用摊销626,434-1,430,486.9-
  处置固定资产、无形资产和其他长期资产的损失864.63--3,909.66-
  固定资产报废损失--12,183.08-
  公允价值变动损失---2,419,469.21-
  财务费用701,883.15-1,308,733.32-
  投资损失-6,593,169.16--11,336,994.51-
  递延所得税-526,161.52-832,211.41-
  其中:递延所得税资产减少-493,173.02-898,487.03-
    递延所得税负债增加-32,988.5--66,275.62-
  存货的减少-2,810,874.76-1,149,861.74-
  经营性应收项目的减少-1,694,589.33-7,765,045.27-
  经营性应付项目的增加-9,706,372.4--9,170,778.14-
  其他--3,470,409.79-
  不涉及现金收支的投资和筹资活动金额其他项目7,321.95-3,101,294.96-
  现金的期末余额1,007,055,665.51-1,067,206,832.73-
  减:现金的期初余额1,067,206,832.73-1,153,801,027.71-
  现金及现金等价物的净增加额-60,151,167.22--86,594,194.98-
公告日期2025-08-282025-04-252025-04-252024-10-25
审计意见(境内)标准无保留意见
TOP↑